NE Stock Analysis: Noble | NYSE

Oil & Gas Drilling | NYSE, USA | Market Cap: 7.219m USD | 12M Return: 73.6% | KYG6610J2093 | Charts, Fundamentals & Technical Analysis

Offshore Drilling, Floaters, Jackups, Drilling Rigs
Total Rating 39
Safety 75
Buy Signal 0.00
Oil & Gas Drilling
Industry Rotation: +30.4
Market Cap: 7.22B
Avg Turnover: 54.0M
Risk 3d forecast
Volatility43.7%
VaR 5th Pctl7.32%
VaR vs Median1.75%
Reward TTM
Sharpe Ratio1.44
Rel. Str. IBD89.1
Rel. Str. Peer Group50 pctl
Character TTM
Beta0.711
Beta Downside1.015
Hurst Exponent0.571
Choppyness62.1%
Drawdowns 3y
Max DD61.68%
CAGR/Max DD0.09
CAGR/Mean DD0.22

Warnings

P/E Ratio 137.0
Interest Coverage Ratio Critical

Tailwinds

Rs Leader

Seasonality 5.3 years of data

Jan +4.8% 21
Feb -1.7% 19
Mar +0.0% 0
Apr -4.3% 47
May +0.4% 0
Jun -1.3% 9
Jul +9.1% 58
Aug -0.5% 9
Sep -2.9% 47
Oct -3.2% 0
Nov +1.0% 0
Dec -0.6% 19

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: NE Noble

Noble Corporation plc is a Houston-based offshore drilling contractor serving the global oil and gas industry. The company provides contract drilling services through a fleet of mobile offshore drilling units, including floaters and jackups, operating across regions such as Africa, the Far East Asia, the North Sea, Oceania, South America, and the U.S. Gulf of America. Founded in 1921, Noble is listed on the NYSE under the ticker NE and is classified within the Energy sector, specifically the Oil & Gas Drilling sub-industry.

Headlines to Watch Out For
  • Tight rig supply pushes offshore dayrates to multi-year highs
  • Brent crude strength reignites offshore exploration and development spending
  • Shareholder returns accelerate as backlog and cash flow expand
Piotroski VR-10 (Strict) 3.5
Net Income: 53.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA -3.78 > 1.0
NWC/Revenue: 16.63% < 20% (prev 16.97%; Δ -0.34% < -1%)
CFO/TA 0.10 > 3% & CFO 749.0m > Net Income 53.7m
Net Debt (1.67b) to EBITDA (570.7m): 2.93 < 3
Current Ratio: 1.76 > 1.5 & < 3
Outstanding Shares: last fiscal year (160.2m) vs prev 5.65% < -2%
Gross Margin: 19.73% > 18% (prev 22.36%; Δ -2.63% > 0.5%)
Asset Turnover: 44.41% > 50% (prev 45.14%; Δ -0.73% > 0%)
Interest Coverage Ratio: 0.02 > 6 (EBIT TTM 2.37m / Interest Expense TTM 153.2m)
Altman Z'' 2.20
A: 0.08 (Total Current Assets 1.26b - Total Current Liabilities 716.8m) / Total Assets 7.16b
B: 0.04 (Retained Earnings 286.6m / Total Assets 7.16b)
C: 0.00 (EBIT TTM 2.37m / Avg Total Assets 7.40b)
D: 1.49 (Book Value of Equity 4.29b / Total Liabilities 2.87b)
Altman-Z'' = 2.20 = BBB
Beneish M -4.00
DSRI: 0.84 (Receivables 612.0m/763.5m, Revenue 3.29b/3.45b)
GMI: 1.13 (GM 22.36% / 19.73%)
AQI: -2.49 (AQ_t -0.18 / AQ_t-1 0.07)
SGI: 0.95 (Revenue 3.29b / 3.45b)
TATA: -0.10 (NI 53.7m - CFO 749.0m) / TA 7.16b)
Beneish M = -5.15 (Cap -4..+1) = AAA
What is the price of NE shares?

As of November 02, 2026, the stock is trading at USD 49.00 with a total of 1,203,699 shares traded. Over the past week, the price has changed by +2.73%, over one month by +16.83%, over three months by +19.49% and over the past year by +73.55%.

Current recommended Stop Loss: 46.10 (which is 5.9% or 1.5 ATR below the current price).

Is NE a buy, sell or hold?

Noble has received a consensus analysts rating of 3.58. Therefore, it is recommended to hold NE.

  • StrongBuy: 3
  • Buy: 1
  • Hold: 8
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the NE price?
Analysts Target Price 46.5 -5.1%
Noble (NE) - Fundamental Data Overview as of 29 October 2026
Market Cap USD = 7.22b (7.22b USD * 1.0 USD.USD)
P/E Trailing = 137.0303
P/E Forward = 20.9644
P/S = 2.5025
P/B = 1.7022
Revenue TTM = 3.29b USD
EBIT TTM = 2.37m USD
EBITDA TTM = 570.7m USD
Long Term Debt = 1.98b USD (from longTermDebt, last fiscal year)
Short Term Debt = 13.9m USD (from shortTermDebt, last fiscal year)
Debt = 2.01b USD (corrected: LT Debt 1.98b + ST Debt 13.9m) + Leases 21.0m
Net Debt = 1.67b USD (calculated: Debt 2.01b - CCE 337.2m)
Enterprise Value = 8.89b USD (7.22b + Debt 2.01b - CCE 337.2m)
Interest Coverage Ratio = 0.02 (Ebit TTM 2.37m / Interest Expense TTM 153.2m)
EV/FCF = 91.74x (Enterprise Value 8.89b / FCF TTM 96.9m)
FCF Yield = 1.09% (FCF TTM 96.9m / Enterprise Value 8.89b)
FCF Margin = 2.95% (FCF TTM 96.9m / Revenue TTM 3.29b)
Net Margin = 1.63% (Net Income TTM 53.7m / Revenue TTM 3.29b)
Gross Margin = 19.73% ((Revenue TTM 3.29b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = none% (prev 37.99%)
Tobins Q-Ratio = 1.24 (Enterprise Value 8.89b / Total Assets 7.16b)
Interest Expense / Debt = 7.62% (Interest Expense 153.2m / Debt 2.01b)
Taxrate = 20.65% (56.4m / 273.1m)
NOPAT = 1.88m (EBIT 2.37m * (1 - 20.65%))
Current Ratio = 1.76 (Total Current Assets 1.26b / Total Current Liabilities 716.8m)
Debt / Equity = 0.47 (Debt 2.01b / totalStockholderEquity, last quarter 4.29b)
Debt / EBITDA = 2.93 (Net Debt 1.67b / EBITDA 570.7m)
Debt / FCF = 17.26 (Net Debt 1.67b / FCF TTM 96.9m)
Total Stockholder Equity = 4.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.73% (Net Income 53.7m / Total Assets 7.16b)
RoE = 1.20% (Net Income TTM 53.7m / Total Stockholder Equity 4.48b)
RoCE = 0.04% (EBIT 2.37m / Capital Employed (Equity 4.48b + L.T.Debt 1.98b))
RoIC = 0.03% (NOPAT 1.88m / Invested Capital 6.29b)
WACC = 7.60% (E(7.22b)/V(9.23b) * Re(8.03%) + D(2.01b)/V(9.23b) * Rd(7.62%) * (1-Tc(0.21)))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 85.11 | Cagr: 4.44%
[DCF] Terminal Value 73.10% ; FCFF base≈215.1m ; Y1≈188.6m ; Y5≈152.4m
[DCF] Fair Price = 4.84 (EV 2.45b - Net Debt 1.67b = Equity 772.7m / Shares 159.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -4.0 | # QB: -1
Revenue Correlation: 81.89 | Revenue CAGR: 10.99% | SUE: N/A | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.15 | Chg30d=-3.28% | Revisions=-17% | Analysts=6
EPS current Year (2026-12-31): EPS=-0.24 | Chg30d=-149.02% | Revisions=+0% | GrowthEPS=-135.8% | GrowthRev=-12.1%
EPS next Year (2027-12-31): EPS=2.06 | Chg30d=+1.35% | Revisions=-29% | GrowthEPS=+956.4% | GrowthRev=+9.2%
[Analyst] Revisions Ratio: -21% (up=4, down=7)